Cargando…
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481482/ https://www.ncbi.nlm.nih.gov/pubmed/37674117 http://dx.doi.org/10.1186/s12883-023-03368-3 |
_version_ | 1785101984032882688 |
---|---|
author | Ailani, Jessica McAllister, Peter Winner, Paul K. Chakhava, George Josiassen, Mette Krog Lindsten, Annika Sperling, Bjørn Ettrup, Anders Cady, Roger |
author_facet | Ailani, Jessica McAllister, Peter Winner, Paul K. Chakhava, George Josiassen, Mette Krog Lindsten, Annika Sperling, Bjørn Ettrup, Anders Cady, Roger |
author_sort | Ailani, Jessica |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10481482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104814822023-09-07 Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial Ailani, Jessica McAllister, Peter Winner, Paul K. Chakhava, George Josiassen, Mette Krog Lindsten, Annika Sperling, Bjørn Ettrup, Anders Cady, Roger BMC Neurol Correction BioMed Central 2023-09-06 /pmc/articles/PMC10481482/ /pubmed/37674117 http://dx.doi.org/10.1186/s12883-023-03368-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Ailani, Jessica McAllister, Peter Winner, Paul K. Chakhava, George Josiassen, Mette Krog Lindsten, Annika Sperling, Bjørn Ettrup, Anders Cady, Roger Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial |
title | Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial |
title_full | Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial |
title_fullStr | Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial |
title_full_unstemmed | Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial |
title_short | Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial |
title_sort | correction: rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized relief trial |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481482/ https://www.ncbi.nlm.nih.gov/pubmed/37674117 http://dx.doi.org/10.1186/s12883-023-03368-3 |
work_keys_str_mv | AT ailanijessica correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT mcallisterpeter correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT winnerpaulk correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT chakhavageorge correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT josiassenmettekrog correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT lindstenannika correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT sperlingbjørn correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT ettrupanders correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial AT cadyroger correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial |